Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status

Alessandro Capucci(Marche Polytechnic University), Jeff S. Healey(Population Health Research Institute), Jorge Wong(Population Health Research Institute), John Boehmer(Penn State Milton S. Hershey Medical Center), Paul W. Jones(Boston Scientific (United States)), Brian Kwan(University of San Diego), Yi Zhang(Boston Scientific (United States)), Rezwan Ahmed(Boston Scientific (United States)), Pramodsingh H. Thakur(Boston Scientific (United States)), Michael R. Gold(Medical University of South Carolina)
JACC. Clinical electrophysiology
November 24, 2021
10.1016/j.jacep.2021.09.015
Cited by 14

Related Papers

Subclinical Atrial Fibrillation and the Risk of Stroke
|New England Journal of Medicine|2012|2.1k
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
|New England Journal of Medicine|2010|1.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
|Circulation|2008|873
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711